Literature DB >> 17526626

Smoking kills (alcoholics)! shouldn't we do something about it?

John Littleton1, Susan Barron, Mark Prendergast, Sara Jo Nixon.   

Abstract

In general, 'drinkers smoke', and a high proportion of the alcohol-dependent population is also nicotine-dependent. Statistically, the majority of alcoholics will die of smoking-related, rather than alcohol-related, disease. This co-dependent sub-population may have higher levels of nicotine dependence, and find smoking cessation more difficult. Major reasons are that concurrent alcohol use, and/or prior alcohol exposure, may change the reinforcing effects of nicotine, and that each drug becomes a pharmacological cue for the expectation of the other. If so, then smokers whose nicotine dependence is impacted by alcohol, represent a large and distinct sub-population in which both the therapeutic and molecular targets for smoking cessation are altered. This, in turn, has implications for the validity of animal models of nicotine reinforcement, and for the development of novel smoking cessation medications. It is no longer possible to ignore the fact that the two most prevalent and damaging addictive drugs in our society are very commonly used by the same individuals. Without a better understanding of the psychological and pharmacological interactions between alcohol and nicotine that impact dependence, we cannot hope to provide appropriate medications for this large and problematic patient group. Our intention in this opinion overview is to use the current literature to provide a framework for future studies into the impact of alcohol use on the reinforcing effects of nicotine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17526626     DOI: 10.1093/alcalc/agm019

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  39 in total

1.  Responses to alcohol and cigarette use during ecologically assessed drinking episodes.

Authors:  Thomas M Piasecki; Phillip K Wood; Saul Shiffman; Kenneth J Sher; Andrew C Heath
Journal:  Psychopharmacology (Berl)       Date:  2012-04-27       Impact factor: 4.530

2.  Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers.

Authors:  Daniel J O Roche; Spencer Bujarski; Emily Hartwell; ReJoyce Green; Lara A Ray
Journal:  Pharmacol Biochem Behav       Date:  2015-04-28       Impact factor: 3.533

3.  Nicotine as a factor in stress responsiveness among detoxified alcoholics.

Authors:  Rebecca Gilbertson; Reginald F Frye; Sara Jo Nixon
Journal:  Alcohol Alcohol       Date:  2010-11-02       Impact factor: 2.826

Review 4.  Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.

Authors:  Stephanie C Licata; Perry F Renshaw
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

5.  Effects of varenicline versus transdermal nicotine replacement therapy on cigarette demand on quit day in individuals with substance use disorders.

Authors:  Cara M Murphy; James MacKillop; Rosemarie A Martin; Jennifer W Tidey; Suzanne M Colby; Damaris J Rohsenow
Journal:  Psychopharmacology (Berl)       Date:  2017-05-13       Impact factor: 4.530

6.  Differences in quit attempts between non-Hispanic Black and White daily smokers: the role of smoking motives.

Authors:  Guadalupe A Bacio; Iris Y Guzman; Jenessa R Shapiro; Lara A Ray
Journal:  Addict Behav       Date:  2014-07-31       Impact factor: 3.913

Review 7.  Brain-behavior relations and effects of aging and common comorbidities in alcohol use disorder: A review.

Authors:  Edith V Sullivan; Adolf Pfefferbaum
Journal:  Neuropsychology       Date:  2019-09       Impact factor: 3.295

8.  Factors associated with alcohol abuse and dependence among public transport workers in the metropolitan region of Belo Horizonte.

Authors:  Najla Ourives Cunha; Luana Giatti; Ada Ávila Assunção
Journal:  Int Arch Occup Environ Health       Date:  2016-03-21       Impact factor: 3.015

9.  Bupropion-SR for smoking reduction and cessation in alcohol-dependent outpatients: a naturalistic, open-label study.

Authors:  Maher Karam-Hage; Jason D Robinson; Ashutosh Lodhi; Kirk J Brower
Journal:  Curr Clin Pharmacol       Date:  2014-05

10.  Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma.

Authors:  Sonia A Duffy; David L Ronis; Scott McLean; Karen E Fowler; Stephen B Gruber; Gregory T Wolf; Jeffrey E Terrell
Journal:  J Clin Oncol       Date:  2009-03-16       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.